HCA Healthcare, Inc. $HCA Stock: State of Alaska Department of Revenue Reduces Stake

State of Alaska Department of Revenue decreased its position in shares of HCA Healthcare, Inc. (NYSE:HCA) by 8.3% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 13,947 shares of the company’s stock after selling 1,269 shares during the quarter. State of Alaska Department of Revenue’s holdings in HCA Healthcare were worth $5,951,000 as of its most recent SEC filing.

A number of other institutional investors have also recently bought and sold shares of the stock. BlackRock Inc. bought a new stake in HCA Healthcare in the 2nd quarter valued at $5,069,974,000. Legal & General Group Plc acquired a new stake in shares of HCA Healthcare in the 2nd quarter valued at about $410,992,000. Jupiter Topco LLC bought a new stake in shares of HCA Healthcare in the second quarter valued at about $371,138,000. Wellington Management Group LLP grew its holdings in shares of HCA Healthcare by 20.5% during the second quarter. Wellington Management Group LLP now owns 4,707,473 shares of the company’s stock worth $1,835,397,000 after buying an additional 799,761 shares in the last quarter. Finally, Bank of America Corp DE acquired a new stake in HCA Healthcare in the 2nd quarter valued at approximately $238,457,000. Institutional investors own 62.73% of the company’s stock.

HCA Healthcare Trading Down 2.2%

Shares of NYSE:HCA traded down $10.11 during trading on Friday, hitting $458.39. 1,725,685 shares of the company were exchanged, compared to its average volume of 1,335,268. HCA Healthcare, Inc. has a fifty-two week low of $353.99 and a fifty-two week high of $556.52. The stock has a market cap of $99.24 billion, a price-to-earnings ratio of 15.35, a P/E/G ratio of 1.58 and a beta of 1.10. The firm has a fifty day moving average price of $426.39 and a two-hundred day moving average price of $419.27.

HCA Healthcare (NYSE:HCA) last released its quarterly earnings data on Friday, July 24th. The company reported $7.59 EPS for the quarter, beating the consensus estimate of $7.56 by $0.03. The company had revenue of $20.23 billion during the quarter, compared to the consensus estimate of $19.76 billion. HCA Healthcare had a negative return on equity of 244.79% and a net margin of 8.77%. The firm’s revenue for the quarter was up 8.7% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $6.84 EPS. As a group, research analysts predict that HCA Healthcare, Inc. will post 29.45 EPS for the current year.

HCA Healthcare Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Wednesday, September 30th. Shareholders of record on Wednesday, September 16th were paid a $0.78 dividend. The ex-dividend date was Wednesday, September 16th. This represents a $3.12 dividend on an annualized basis and a yield of 0.7%. HCA Healthcare’s dividend payout ratio (DPR) is currently 10.45%.

Wall Street Analyst Weigh In

A number of research firms have weighed in on HCA. JPMorgan Chase & Co. reduced their price target on HCA Healthcare from $490.00 to $425.00 and set a “neutral” rating for the company in a research report on Thursday, August 20th. The Goldman Sachs Group lowered their price objective on shares of HCA Healthcare from $558.00 to $485.00 and set a “buy” rating on the stock in a report on Tuesday, July 28th. BMO Capital Markets assumed coverage on shares of HCA Healthcare in a report on Tuesday, September 22nd. They set an “outperform” rating and a $495.00 target price for the company. Royal Bank Of Canada raised their target price on shares of HCA Healthcare from $435.00 to $496.00 and gave the company an “outperform” rating in a research report on Wednesday, October 7th. Finally, Oppenheimer cut their price target on shares of HCA Healthcare from $520.00 to $485.00 and set an “outperform” rating on the stock in a research report on Monday, July 27th. Sixteen investment analysts have rated the stock with a Buy rating, seven have issued a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average target price of $467.61.

HCA Healthcare Company Profile

HCA Healthcare, Inc is a provider of healthcare services in the United States. Through its network of hospitals and other healthcare facilities, the company delivers services including emergency and urgent care, surgery, inpatient and outpatient treatment, women’s and children’s care, cardiology, oncology, orthopedics, and behavioral health services.

HCA Healthcare also operates physician practices, ambulatory surgery centers, freestanding emergency rooms, diagnostic facilities, and other outpatient care sites.